Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Laduron

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Neuroscience|August 1, 1992
Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transportM C Burgevin, M N Castel, D Quarteronet, et al.
Molecular Pharmacology|March 1, 1982
[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional roleJ E Leysen, C J Niemegeers, J M Van Nueten, et al.
Sleep|April 1, 1992
RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in ratsJ M Stutzmann, B Eon, M Lucas, et al.
Annals of the New York Academy of Sciences|January 1, 1992
Striatal injection of neurotensin increases tyrosine hydroxylase mRNA in substantia nigraM C Burgevin, P M Laduron, D Quarteronnet, et al.
Journal of Medicinal Chemistry|September 1, 1986
In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserinW Wouters, C G Janssen, J Van Dun, et al.
Biochemical Pharmacology|May 15, 1978
Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatumJ G Cannon, B Costall, P M Laduron, et al.
Neuroscience Letters|July 9, 1993
Postnatal ontogeny of the rat brain neurotensin receptor mRNAE Hermans, A P Jeanjean, P M Laduron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsyJ M Maloteaux, E C Laterre, P M Laduron, et al.
Biochemical Pharmacology|October 1, 1988
In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellumA Boireau, M Martel, G Farges, et al.
Journal of Neurochemistry|May 1, 1991
Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neuronsM N Castel, D Faucher, F Cuiné, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Neuroscience|August 1, 1992
Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transportM C Burgevin, M N Castel, D Quarteronet, et al.
Molecular Pharmacology|March 1, 1982
[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional roleJ E Leysen, C J Niemegeers, J M Van Nueten, et al.
Sleep|April 1, 1992
RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in ratsJ M Stutzmann, B Eon, M Lucas, et al.
Annals of the New York Academy of Sciences|January 1, 1992
Striatal injection of neurotensin increases tyrosine hydroxylase mRNA in substantia nigraM C Burgevin, P M Laduron, D Quarteronnet, et al.
Journal of Medicinal Chemistry|September 1, 1986
In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserinW Wouters, C G Janssen, J Van Dun, et al.
Biochemical Pharmacology|May 15, 1978
Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatumJ G Cannon, B Costall, P M Laduron, et al.
Neuroscience Letters|July 9, 1993
Postnatal ontogeny of the rat brain neurotensin receptor mRNAE Hermans, A P Jeanjean, P M Laduron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsyJ M Maloteaux, E C Laterre, P M Laduron, et al.
Biochemical Pharmacology|October 1, 1988
In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellumA Boireau, M Martel, G Farges, et al.
Journal of Neurochemistry|May 1, 1991
Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neuronsM N Castel, D Faucher, F Cuiné, et al.
Pageof 14